Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Genome characteristics of Bordetella pertussis isolates from Tunisia.

Ben Fraj I, Bouchez V, Smaoui H, Kechrid A, Brisse S.

J Med Microbiol. 2019 Sep;68(9):1320-1323. doi: 10.1099/jmm.0.001042.

PMID:
31329091
2.

Bordetella parapertussis Bacteremia: Clinical Expression and Bacterial Genomics.

Toubiana J, Azarnoush S, Bouchez V, Landier A, Guillot S, Matczak S, Bonacorsi S, Brisse S.

Open Forum Infect Dis. 2019 Mar 7;6(4):ofz122. doi: 10.1093/ofid/ofz122. eCollection 2019 Apr.

3.

Complete Genome Sequences of Bordetella pertussis Clinical Isolate FR5810 and Reference Strain Tohama from Combined Oxford Nanopore and Illumina Sequencing.

Bouchez V, Baines SL, Guillot S, Brisse S.

Microbiol Resour Announc. 2018 Nov 15;7(19). pii: e01207-18. doi: 10.1128/MRA.01207-18. eCollection 2018 Nov.

4.

Pertussis epidemiology in Tunisian infants and children and characterization of Bordetella pertussis isolates: results of a 9-year surveillance study, 2007 to 2016.

Ben Fraj I, Kechrid A, Guillot S, Bouchez V, Brisse S, Guiso N, Smaoui H.

J Med Microbiol. 2019 Feb;68(2):241-247. doi: 10.1099/jmm.0.000892. Epub 2018 Dec 10.

PMID:
30526740
5.

Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough.

Bouchez V, Guglielmini J, Dazas M, Landier A, Toubiana J, Guillot S, Criscuolo A, Brisse S.

Emerg Infect Dis. 2018 Jun;24(6):988-994. doi: 10.3201/eid2406.171464.

6.

Characterization of Post-Translational Modifications and Cytotoxic Properties of the Adenylate-Cyclase Hemolysin Produced by Various Bordetella pertussis and Bordetella parapertussis Isolates.

Bouchez V, Douché T, Dazas M, Delaplane S, Matondo M, Chamot-Rooke J, Guiso N.

Toxins (Basel). 2017 Sep 26;9(10). pii: E304. doi: 10.3390/toxins9100304.

7.

The length of poly(C) stretch in the Bordetella pertussis Pfim3 promoter determines the vag or vrg function of the fim3 gene.

Otsuka N, Guiso N, Bouchez V.

Microbiology. 2017 Sep;163(9):1364-1368. doi: 10.1099/mic.0.000514. Epub 2017 Aug 15.

PMID:
28809156
8.

Bordetella holmesii: Lipid A Structures and Corresponding Genomic Sequences Comparison in Three Clinical Isolates and the Reference Strain ATCC 51541.

Bouchez V, AlBitar-Nehmé S, Novikov A, Guiso N, Caroff M.

Int J Mol Sci. 2017 May 18;18(5). pii: E1080. doi: 10.3390/ijms18051080.

9.

New Data on Vaccine Antigen Deficient Bordetella pertussis Isolates.

Bouchez V, Hegerle N, Strati F, Njamkepo E, Guiso N.

Vaccines (Basel). 2015 Sep 14;3(3):751-70. doi: 10.3390/vaccines3030751.

10.

Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.

Bouchez V, Guiso N.

Pathog Dis. 2015 Oct;73(7). pii: ftv055. doi: 10.1093/femspd/ftv055. Epub 2015 Aug 4. Review.

PMID:
26242280
11.

Structure activity characterization of Bordetella petrii lipid A, from environment to human isolates.

Basheer SM, Bouchez V, Novikov A, Augusto LA, Guiso N, Caroff M.

Biochimie. 2016 Jan;120:87-95. doi: 10.1016/j.biochi.2015.07.006. Epub 2015 Jul 8.

PMID:
26164553
12.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

13.

Bordetella parapertussis isolates not expressing pertactin circulating in France.

Bouchez V, Brun D, Dore G, Njamkepo E, Guiso N.

Clin Microbiol Infect. 2011 May;17(5):675-82. doi: 10.1111/j.1469-0691.2010.03303.x.

14.

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.

Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N.

Vaccine. 2009 Oct 9;27(43):6034-41. doi: 10.1016/j.vaccine.2009.07.074. Epub 2009 Aug 8.

PMID:
19666155
15.

Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination.

Bouchez V, Caro V, Levillain E, Guigon G, Guiso N.

PLoS One. 2008 Jun 18;3(6):e2437. doi: 10.1371/journal.pone.0002437.

16.

Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?

Caro V, Bouchez V, Guiso N.

J Clin Microbiol. 2008 Jun;46(6):2125-8. doi: 10.1128/JCM.02484-07. Epub 2008 Apr 2.

17.

Pertussis in Argentina and France.

Caro V, Bouchez V, Guiso N, Gatti B, Agosti MR, Ayala SE.

Vaccine. 2007 May 30;25(22):4335-9. Epub 2006 Aug 31.

PMID:
17229502
18.

Efficient syntheses of 1-bromodeoxy-, 1-azidodeoxy- and 1-aminodeoxypentitols from unprotected D-pentono-1,4-lactones.

Bouchez V, Stasik I, Beaupère D.

Carbohydr Res. 2000 Jan 12;323(1-4):213-7.

PMID:
10782304

Supplemental Content

Loading ...
Support Center